Morris, T.
Strömmer, S.
Vogel, C.
Harvey, N. C.
Cooper, C.
Inskip, H.
Woods-Townsend, K.
Baird, J.
Barker, M.
Lawrence, W.
Funding for this research was provided by:
Nutricia Early Life Nutrition (NA)
Article History
Received: 28 April 2019
Accepted: 29 March 2020
First Online: 25 April 2020
Ethics approval and consent to participate
: The SPRING trial has approval from the Medicines and Healthcare products Regulatory Agency (MHRA), Southampton and South West Hampshire Research Ethics Committee and from University Hospital Southampton Foundation Trust (UHSFT) R&D. For this interview study, right of access was received from UHSFT R&D and the substantial amendment to the SPRING protocol to include these interviews was approved by the South Central – Hampshire B Research Ethics Committee. All patient-facing materials received ethics approval before recruitment to interviews began and patients provided both written and verbal consent to take part in this interview study.
: Not applicable.
: JB, MB, NCH and TM have received funding from Nutricia Early Life Nutrition, outside the submitted work. Members of HI’s team have received funding from Nestec and Abbott Nutrition. CC reports personal fees, consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, Amgen, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, and Takeda, outside the submitted work. NCH reports personal fees, consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, and Internis Pharma, outside the submitted work. WL reports consultancy and lecture fees from Nutricia Early Life Nutrition, outside the submitted work. JB, CV and CC have a non-financial research collaboration with Iceland Foods Ltd. that involves independent evaluation of in-store interventions. This collaboration bears no relationship to the study described in this paper.All other authors have no conflicts of interest to declare.